Vivo Capital IX, LLC is 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS). They have made 5 open-market trades across 2 companies since 2021, most recently 2023-08-09.
CIK 0001750698
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12.0M since 2023, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IOBT | BUY | 2023-08-09 | 2023-08-10 | $1.90 | $12.0M | +2.7% | -10.7% | -49.3% |
| TARS | SELL | 2022-05-05 | 2022-05-05 | $12.25 | $132K | +7.9% | +10.6% | +37.4% |
| TARS | SELL | 2021-06-23 | 2021-06-25 | $29.77 | $1.9M | -3.6% | -16.9% | -23.5% |
| TARS | SELL | 2021-06-21 | 2021-06-25 | $29.05 | $5.9M | -3.6% | -16.9% | -23.5% |
| TARS | SELL | 2021-04-14 | 2021-04-16 | $30.37 | $12K | +9.0% | +4.5% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.